Taken together, we suggested that 10 aforementioned hub genes are promising therapeutic targets of HCC and the ATIC/BIRC5 prognostic signature is a practical prognostic indicator for HCC patients. This evidence concerns the gene BIRC5 and hepatocellular carcinoma.